Essex Investment Management CO LLC Aquestive Therapeutics, Inc. Transaction History
Essex Investment Management CO LLC
- $483 Million
- Q1 2024
A detailed history of Essex Investment Management CO LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 612,949 shares of AQST stock, worth $1.59 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
612,949
Previous 846,167
27.56%
Holding current value
$1.59 Million
Previous $1.71 Million
52.78%
% of portfolio
0.54%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$25.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$14.4 Million2.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$8.43 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.77 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$4.02 Million0.06% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $139M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...